Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 16, 2010

View Archived Issues

TIGER-1 data detail potential of denufosol in cystic fibrosis

7TM Pharma reports encouraging phase I data on TM-38837

FSH receptor is a possible marker of several cancer types

Vertex Pharma enrolls additional cohort in phase II telaprevir/VX-222 trial

Furiex Pharma presents phase II data on JNJ-Q2

Trans-sodium crocetinate is beneficial in PAD-related intermittent claudication

Suven Life Sciences presents SUVN-F90101 and SUVN-F91201

AB Therapeutics reports data on two anticancer agents in model of NSCLC

MicroDose Therapeutx receives Therapeutic Discovery Project grants

ProtAffin receives funding from Austrian FFG to develop PA-401

Abbott describes analgesic effects of A-1048400

Nektar Therapeutics presents new tyrosine protein kinase inhibitor-oligomer conjugates

XenoPort discloses new GABA(B) receptor ligands

Karus Therapeutics claims new histone deacetylase inhibitors

Italian scientists discover new selective androgen receptor modulators

FDA approves Eisai's Halaven for late-stage breast cancer

Pozen achieves milestone under Vivomo partnership with AstraZeneca

BioWa licenses Potelligent technology to Agensys

StemCells files application in Switzerland for clinical trial of HuCNS-SC

FluCide Nanoviricides reduce viral load in model of lethal flu

Agios Pharma claims new activators of pyruvate kinase isozymes M1/M2

Health Canada approves Vitaros as first-line therapy for erectile dysfunction

Amakem receives Flemish IWT grant for ROCK inhibitor program in COPD

Merrion Pharma plans phase III study of Orazol in breast cancer

Horizon Pharma receives U.S. government grant for HZT-501

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...